Genetics in retinal diseases project,
Role: Investigator,
National Eye Institute/NIH/DHHS,
(10/2025 - 10/2026)
Status: Approved
For Profit Organization
A Randomized clinical trial evaluating combination Faricimab + PRP vs. Vitrectomy+ Endolaser for treatment of Proliferative Diabetic Retinopathy,
Role: Investigator,
Diabetic Retinopathy Clinical Research Network (DRCRnet),
(08/2025)
Status: Approved
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-1),
Role: Investigator,
4D Molecular Therapeutics, Inc.,
(05/2025 - 05/2026)
Status: Approved
A NON-RANDOMIZED, OPEN LABEL, SAFETY AND EFFICACY STUDY EVALUATING KAMUVUDINE-8 (K8) FOR THE TREATMENT OF PATIENTS WITH GEOGRAPHIC ATROPHY,
Role: Investigator,
Inflammasome Therapeutics,
(02/2025)
Status: Approved